Statistical colocalization of monocyte gene expression and genetic risk variants for type 1 diabetes
Year: 2012
Type: article
Abstract: One mechanism by which disease-associated DNA variation can alter disease risk is altering gene expression. However, linkage disequilibrium (LD) between variants, mostly single-nucleotide polymorphisms (SNPs), means it is not sufficient to show that a particular variant associates with both disease and expression, as there could be two distinct causal variants in LD. Here, we describe a formal statistical test of colocalization and apply it to type 1 diabetes (T1D)-associated regions identified mostly through genome-wide association studies and expression quantitative trait loci (eQTLs) discovered in a recently determined large monocyte expression data set from the Gutenberg Health Study (1370 individuals), with confirmation sought in an additional data set from the Cardiogenics Transcriptome Study (558 individuals). We excluded 39 out of 60 overlapping eQTLs in 49 T1D regions from possible colocalization and identified 21 coincident eQTLs, representing 21 genes in 14 distinct T1D regions. Our results reflect the importance of monocyte (and their derivatives, macrophage and dendritic cell) gene expression in human T1D and support the candidacy of several genes as causal factors in autoimmune pancreatic beta-cell destruction, including AFF3, CD226, CLECL1, DEXI, FKRP, PRKD2, RNLS, SMARCE1 and SUOX, in addition to the recently described GPR183 (EBI2) gene.
Source: Human Molecular Genetics
DOI: 10.1093/hmg/dds098
Language: English
Subfield: Genetics
Domain: Life Sciences
Keywords: type 1 diabetes, colocalization, expression quantitative trait loci, monocyte gene expression, genetic risk variants, linkage disequilibrium, autoimmune beta-cell destruction, monocytes, macrophages, dendritic cells, causal variants, GPR183, EBI2, SMARCE1, CD226, DEXi, FKRP, protein kinase D2, AFF3
Open Access status: hybrid
Estimated APC paid: $4,390
Funders: Juvenile Diabetes Research Foundation United States of America, Wellcome Trust, National Institute for Health and Care Research, University of Cambridge, University of Leicester, European Commission, University of Bristol, Agence Nationale de la Recherche, Bundesministerium für Bildung und Forschung, Medical Research Council, Cambridge Institute for Medical Research, University of Cambridge, National Human Genome Research Institute, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Child Health and Human Development
Awards: G1137313802, Novel immunotherapies for type 1 diabetes, Diabetes and Inflammation Laboratory., G3153491656, G3207356259, JDRF/WT Diabetes and Inflammation Laboratory., Genes and Pathways in Type 1 Diabetes., G393177772, G4621420766, NIHR Senior Investigator Award, G5568298347, A national DNA control series for genetic case-control studies based on the British 1958 birth cohort, G5702163051, G575173146, G5800340488, Verbundprojekt: Atherogenomics - Teilprojekt, A1, A2, B2, C2, D1, D2, F1: Identifizierung und Charakterisierung von Risikogenen für Herzinfarkt und coronare Herzkrankheit, Verbundkoordination, Type 1 Diabetes Genetics Consortium, Cambridge Institute for Medical Research (CIMR)., G7558636403, Verbundprojekt: Atherogenomics - Teilprojekt, A3, D1: Genomik, funktionelle Analysen und Genexpressionsstudien bei subklinischen Phänotypen kardiovaskulärer Erkrankungen, G8900108227, The genetics of weight, BMI, adiposity and obesity, Design and implementation of large-scale genetic association studies of commondiseases.
OpenAlex ID: W2129814942
